๐ฐ Quantum Genomics News
Page 3 - Quantum Genomics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Quantum Genomics. Real-time updates on events, politics, business and more.
August 31, 2022
DJ Quantum Genomics (ALQGC): Initiation - A fresh take on cardiovascular medicine Edison Investment Research Limited Quantum Genomics (ALQGC): Initiation - A fresh take on cardiovascular medicine 31-Aug-2022
August 24, 2022
The findings provide insight into the relationship between cardiovascular biomarkers, coronary anatomical complexity, and incident clinical events.
June 27, 2022
Quantum Genomics announces the appointment of its new Scientific Advisory Board Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development
June 27, 2022
PARIS, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the...
May 10, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 9, 2022
Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing
May 4, 2022
Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs Quantum Genomics (Euronext Growth: ALQGC, OTCQX: QNNTF), a biopharmaceutical company specializing in the development
April 28, 2022
Quantum Genomics announces successful capital raising with a gross sum of approximatelyย โฌ15.6 Mโฌ Quantum Genomics has equipped itself with new financial means to pursue the development of
April 28, 2022
Quantum Genomics publishes its results for fiscal 2021 and gives an update on its activity Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the
April 28, 2022
28.04.2022 - PARIS, April 28, 2022 (GLOBE NEWSWIRE) - Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain in order to address ... Seite 1